Accelerating Upstream Bioprocess Development Through Data Driven Decisions

Cell line development scientists and upstream bioprocess engineers aim at optimizing biotherapeutics production processes to maximize drug product quality, yield, and manufacturing efficiency. Currently, information on critical process and product attributes required for informed decision making is often insufficient and not readily available. This has a negative impact on the process robustness, throughput, and outcome.

Direct measurement of cell culture media and product quality attributes (PQAs) has recently been offered thanks to the Waters BioAccord™ LC-MS system with dedicated workflows for process analytics of biopharmaceuticals. The BioAccord™ LC-MS can be directly coupled to multi parallel bioreactor systems, like the Sartorius Ambr® 15 or 250 HT platforms, for accelerated process development.

With this integrated solution, process engineers have direct access to the information they need to be in control: drug substance quality and yield can be maximized, process and product related impurities minimized, and more robust processes can be developed, thereby de-risking batch failure. This ultimately results in accelerated drug product development and manufacturing release from months or weeks to days, saving time and resources but more importantly enable faster delivery of safer treatments to patients.

Please join us as Magnus Wetterhall will present how Waters BioAccord™ LC-MS system offer enhanced capabilities for direct measurements of critical process and product quality attributes in cell line and process development and thereby enabling you to make more informed decisions with your own high-quality data.

Presenter: Magnus Wetterhall, Ph.D. (Global Marketing Manager – Bioprocessing, Waters Corporation)

Magnus Wetterhall has more than 25 years’ experience in upstream & downstream bioprocessing, advanced mass spectrometry, biomarker discovery, protein characterization, working at start-ups, large biotech companies as well as academics. Magnus earned his M.Sc. and Ph.D. degree in analytical chemistry at Uppsala University, Sweden. He has published over 40 scientific papers and 50 posters in the areas of mass spectrometry, biomolecule characterization and bioseparations, and has been an invited presenter at national and international conferences on these topics. He is currently the Global Marketing Manager at Waters Corporation – Bioprocessing, where he is dedicated to deliver analytical solutions to advance upstream and downstream bioprocess.

Presenter: Terence Teo (BioPharma/BMR Market Development Manager, APAC, Waters Corporation)

Terence Teo has more than 15 years of experience in bioprocessing, specializing in downstream processing R&D during the early phase of his career before moving to business development roles in GE Life Sciences (now Cytiva), Pall Biotech and most recently, Waters Corporation. Terence is motivated in supporting regional customers in APAC with technologies enabling continuous bioprocessing. He is currently working actively in Waters to drive the use of LC-MS analytical solutions to support near real-time CQA measurement in bioprocess applications, as well as use of LC-MS in multi-attribute method (MAM) and emerging drug modalities such as mRNA and viral vectors. Terence earned his M.Eng degree in Chemical and Biomolecular Engineering at National University of Singapore (NUS).